том 17 издание 5 страницы 421-433

DNA Topoisomerases and Their Poisoning by Anticancer and Antibacterial Drugs

Тип публикацииJournal Article
Дата публикации2010-05-28
SJR
CiteScore
Impact factor
ISSN10745521, 18791301
Drug Discovery
Biochemistry
Molecular Biology
General Medicine
Pharmacology
Clinical Biochemistry
Molecular Medicine
Краткое описание
DNA topoisomerases are the targets of important anticancer and antibacterial drugs. Camptothecins and novel noncamptothecins in clinical development (indenoisoquinolines and ARC-111) target eukaryotic type IB topoisomerases (Top1), whereas human type IIA topoisomerases (Top2α and Top2β) are the targets of the widely used anticancer agents etoposide, anthracyclines (doxorubicin, daunorubicin), and mitoxantrone. Bacterial type II topoisomerases (gyrase and Topo IV) are the targets of quinolones and aminocoumarin antibiotics. This review focuses on the molecular and biochemical characteristics of topoisomerases and their inhibitors. We also discuss the common mechanism of action of topoisomerase poisons by interfacial inhibition and trapping of topoisomerase cleavage complexes.
Найдено 
Для доступа к списку цитирований публикации необходимо авторизоваться.
Для доступа к списку профилей, цитирующих публикацию, необходимо авторизоваться.

Топ-30

Журналы

5
10
15
20
25
30
35
40
45
50
International Journal of Molecular Sciences
48 публикаций, 3.08%
European Journal of Medicinal Chemistry
41 публикация, 2.63%
Nucleic Acids Research
31 публикация, 1.99%
Scientific Reports
29 публикаций, 1.86%
Journal of Medicinal Chemistry
26 публикаций, 1.67%
Molecules
25 публикаций, 1.61%
Journal of Biological Chemistry
22 публикации, 1.41%
PLoS ONE
22 публикации, 1.41%
Cancers
20 публикаций, 1.28%
Bioorganic and Medicinal Chemistry
20 публикаций, 1.28%
Bioorganic Chemistry
19 публикаций, 1.22%
Bioorganic and Medicinal Chemistry Letters
19 публикаций, 1.22%
Proceedings of the National Academy of Sciences of the United States of America
14 публикаций, 0.9%
Nature Communications
13 публикаций, 0.83%
RSC Advances
13 публикаций, 0.83%
Oncotarget
12 публикаций, 0.77%
Archiv der Pharmazie
11 публикаций, 0.71%
Biochemistry
11 публикаций, 0.71%
Cancer Drug Discovery and Development
11 публикаций, 0.71%
Biochemical Pharmacology
10 публикаций, 0.64%
DNA Repair
10 публикаций, 0.64%
Molecular Cancer Therapeutics
9 публикаций, 0.58%
Molecular Pharmacology
8 публикаций, 0.51%
ChemistrySelect
8 публикаций, 0.51%
Chemical Research in Toxicology
8 публикаций, 0.51%
Cancer Research
8 публикаций, 0.51%
Pharmaceuticals
7 публикаций, 0.45%
Frontiers in Oncology
7 публикаций, 0.45%
Cell Death and Disease
7 публикаций, 0.45%
5
10
15
20
25
30
35
40
45
50

Издатели

50
100
150
200
250
300
350
400
Elsevier
383 публикации, 24.6%
Springer Nature
220 публикаций, 14.13%
MDPI
148 публикаций, 9.51%
Wiley
118 публикаций, 7.58%
American Chemical Society (ACS)
104 публикации, 6.68%
Taylor & Francis
59 публикаций, 3.79%
Oxford University Press
56 публикаций, 3.6%
Royal Society of Chemistry (RSC)
55 публикаций, 3.53%
Cold Spring Harbor Laboratory
49 публикаций, 3.15%
Frontiers Media S.A.
34 публикации, 2.18%
Public Library of Science (PLoS)
26 публикаций, 1.67%
American Association for Cancer Research (AACR)
23 публикации, 1.48%
American Society for Biochemistry and Molecular Biology
22 публикации, 1.41%
Bentham Science Publishers Ltd.
20 публикаций, 1.28%
Proceedings of the National Academy of Sciences (PNAS)
14 публикаций, 0.9%
Impact Journals
13 публикаций, 0.83%
Hindawi Limited
13 публикаций, 0.83%
American Society for Pharmacology and Experimental Therapeutics
11 публикаций, 0.71%
Pleiades Publishing
11 публикаций, 0.71%
American Society for Microbiology
10 публикаций, 0.64%
American Association for the Advancement of Science (AAAS)
10 публикаций, 0.64%
Pharmaceutical Society of Japan
9 публикаций, 0.58%
SAGE
8 публикаций, 0.51%
eLife Sciences Publications
7 публикаций, 0.45%
Portland Press
5 публикаций, 0.32%
Spandidos Publications
5 публикаций, 0.32%
European Molecular Biology Organization
5 публикаций, 0.32%
Ovid Technologies (Wolters Kluwer Health)
4 публикации, 0.26%
IntechOpen
4 публикации, 0.26%
50
100
150
200
250
300
350
400
  • Мы не учитываем публикации, у которых нет DOI.
  • Статистика публикаций обновляется еженедельно.

Вы ученый?

Создайте профиль, чтобы получать персональные рекомендации коллег, конференций и новых статей.
Метрики
1.6k
Поделиться
Цитировать
ГОСТ |
Цитировать
Pommier Y. et al. DNA Topoisomerases and Their Poisoning by Anticancer and Antibacterial Drugs // Chemistry & Biology. 2010. Vol. 17. No. 5. pp. 421-433.
ГОСТ со всеми авторами (до 50) Скопировать
Pommier Y., Leo E., Zhang H., Marchand C. DNA Topoisomerases and Their Poisoning by Anticancer and Antibacterial Drugs // Chemistry & Biology. 2010. Vol. 17. No. 5. pp. 421-433.
RIS |
Цитировать
TY - JOUR
DO - 10.1016/j.chembiol.2010.04.012
UR - https://doi.org/10.1016/j.chembiol.2010.04.012
TI - DNA Topoisomerases and Their Poisoning by Anticancer and Antibacterial Drugs
T2 - Chemistry & Biology
AU - Pommier, Yves
AU - Leo, Elisabetta
AU - Zhang, Hongliang
AU - Marchand, Christophe
PY - 2010
DA - 2010/05/28
PB - Elsevier
SP - 421-433
IS - 5
VL - 17
PMID - 20534341
SN - 1074-5521
SN - 1879-1301
ER -
BibTex |
Цитировать
BibTex (до 50 авторов) Скопировать
@article{2010_Pommier,
author = {Yves Pommier and Elisabetta Leo and Hongliang Zhang and Christophe Marchand},
title = {DNA Topoisomerases and Their Poisoning by Anticancer and Antibacterial Drugs},
journal = {Chemistry & Biology},
year = {2010},
volume = {17},
publisher = {Elsevier},
month = {may},
url = {https://doi.org/10.1016/j.chembiol.2010.04.012},
number = {5},
pages = {421--433},
doi = {10.1016/j.chembiol.2010.04.012}
}
MLA
Цитировать
Pommier, Yves, et al. “DNA Topoisomerases and Their Poisoning by Anticancer and Antibacterial Drugs.” Chemistry & Biology, vol. 17, no. 5, May. 2010, pp. 421-433. https://doi.org/10.1016/j.chembiol.2010.04.012.